144 related articles for article (PubMed ID: 18637642)
1. Evaluation of a sequential global test of improved recovery following stroke as applied to the ICTUS trial of citicoline.
Bolland K; Whitehead J; Cobo E; Secades JJ
Pharm Stat; 2009; 8(2):136-49. PubMed ID: 18637642
[TBL] [Abstract][Full Text] [Related]
2. Citicoline in the treatment of acute ischaemic stroke: an international, randomised, multicentre, placebo-controlled study (ICTUS trial).
Dávalos A; Alvarez-Sabín J; Castillo J; Díez-Tejedor E; Ferro J; Martínez-Vila E; Serena J; Segura T; Cruz VT; Masjuan J; Cobo E; Secades JJ;
Lancet; 2012 Jul; 380(9839):349-57. PubMed ID: 22691567
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of oral citicoline in acute ischemic stroke: drug surveillance study in 4,191 cases.
Cho HJ; Kim YJ
Methods Find Exp Clin Pharmacol; 2009 Apr; 31(3):171-6. PubMed ID: 19536360
[TBL] [Abstract][Full Text] [Related]
4. The effects of citicoline on acute ischemic stroke: a review.
Overgaard K
J Stroke Cerebrovasc Dis; 2014 Aug; 23(7):1764-9. PubMed ID: 24739589
[TBL] [Abstract][Full Text] [Related]
5. Citicoline: update on a promising and widely available agent for neuroprotection and neurorepair.
Saver JL
Rev Neurol Dis; 2008; 5(4):167-77. PubMed ID: 19122569
[TBL] [Abstract][Full Text] [Related]
6. Citicoline in the treatment of acute ischaemic stroke: an international, randomized, multicentre, placebo-controlled study (ICTUS trial) is the use of Citicoline is beneficial for acute ischaemic stroke?
Nomani F; Kamal AK
J Pak Med Assoc; 2013 Nov; 63(11):1445. PubMed ID: 24392540
[No Abstract] [Full Text] [Related]
7. Methods and processes for the reanalysis of the NINDS tissue plasminogen activator for acute ischemic stroke treatment trial.
Hertzberg V; Ingall T; O'Fallon W; Asplund K; Goldfrank L; Louis T; Christianson T
Clin Trials; 2008; 5(4):308-15. PubMed ID: 18697845
[TBL] [Abstract][Full Text] [Related]
8. Percent change on the National Institutes of Health Stroke Scale: a useful acute stroke outcome measure.
Bruno A; Saha C; Williams LS
J Stroke Cerebrovasc Dis; 2009 Jan; 18(1):56-9. PubMed ID: 19110146
[TBL] [Abstract][Full Text] [Related]
9. Citicoline for acute ischemic stroke in Mexican hospitals: a retrospective postmarketing analysis.
Leon-Jimenez C; Chiquete E; Cantu C; Miramontes-Saldana MJ; Andrade-Ramos MA; Ruiz-Sandoval JL
Methods Find Exp Clin Pharmacol; 2010 Jun; 32(5):325-30. PubMed ID: 20664823
[TBL] [Abstract][Full Text] [Related]
10. The albumin in acute stroke trial (ALIAS); design and methodology.
Hill MD; Moy CS; Palesch YY; Martin R; Dillon CR; Waldman BD; Patterson L; Mendez IM; Ryckborst KJ; Tamariz D; Ginsberg MD;
Int J Stroke; 2007 Aug; 2(3):214-9. PubMed ID: 18705947
[TBL] [Abstract][Full Text] [Related]
11. Oral citicoline in acute ischemic stroke: an individual patient data pooling analysis of clinical trials.
Dávalos A; Castillo J; Alvarez-Sabín J; Secades JJ; Mercadal J; López S; Cobo E; Warach S; Sherman D; Clark WM; Lozano R
Stroke; 2002 Dec; 33(12):2850-7. PubMed ID: 12468781
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic applications of citicoline for stroke and cognitive dysfunction in the elderly: a review of the literature.
Conant R; Schauss AG
Altern Med Rev; 2004 Mar; 9(1):17-31. PubMed ID: 15005642
[TBL] [Abstract][Full Text] [Related]
13. Citicoline. Ferrer Internacional.
Alexandrov AV
Curr Opin Investig Drugs; 2001 Dec; 2(12):1757-62. PubMed ID: 11892942
[TBL] [Abstract][Full Text] [Related]
14. Incorporating intermediate binary responses into interim analyses of clinical trials: a comparison of four methods.
Whitehead A; Sooriyarachchi MR; Whitehead J; Bolland K
Stat Med; 2008 May; 27(10):1646-66. PubMed ID: 17886243
[TBL] [Abstract][Full Text] [Related]
15. Citicoline for Acute Ischemic Stroke: A Systematic Review and Formal Meta-analysis of Randomized, Double-Blind, and Placebo-Controlled Trials.
Secades JJ; Alvarez-Sabín J; Castillo J; Díez-Tejedor E; Martínez-Vila E; Ríos J; Oudovenko N
J Stroke Cerebrovasc Dis; 2016 Aug; 25(8):1984-96. PubMed ID: 27234918
[TBL] [Abstract][Full Text] [Related]
16. A randomized efficacy trial of citicoline in patients with acute ischemic stroke.
Clark WM; Williams BJ; Selzer KA; Zweifler RM; Sabounjian LA; Gammans RE
Stroke; 1999 Dec; 30(12):2592-7. PubMed ID: 10582983
[TBL] [Abstract][Full Text] [Related]
17. The ALIAS (ALbumin In Acute Stroke) Phase III randomized multicentre clinical trial: design and progress report.
Ginsberg MD; Palesch YY; Hill MD
Biochem Soc Trans; 2006 Dec; 34(Pt 6):1323-6. PubMed ID: 17073812
[TBL] [Abstract][Full Text] [Related]
18. A randomized dose-response trial of citicoline in acute ischemic stroke patients. Citicoline Stroke Study Group.
Clark WM; Warach SJ; Pettigrew LC; Gammans RE; Sabounjian LA
Neurology; 1997 Sep; 49(3):671-8. PubMed ID: 9305321
[TBL] [Abstract][Full Text] [Related]
19. How important is surrogate consent for stroke research?
Flaherty ML; Karlawish J; Khoury JC; Kleindorfer D; Woo D; Broderick JP
Neurology; 2008 Nov; 71(20):1566-71. PubMed ID: 18753472
[TBL] [Abstract][Full Text] [Related]
20. A phase III randomized efficacy trial of 2000 mg citicoline in acute ischemic stroke patients.
Clark WM; Wechsler LR; Sabounjian LA; Schwiderski UE;
Neurology; 2001 Nov; 57(9):1595-602. PubMed ID: 11706098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
